Drug Profile
PW 4159
Alternative Names: PW4159Latest Information Update: 20 Aug 2009
Price :
$50
*
At a glance
- Originator Penwest Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Muscle spasticity
Most Recent Events
- 26 Apr 2007 Phase-I clinical trials in Spasticity in USA (unspecified route)